Review



anti-cd44 [im7] anti-mouse, apc-efluor 780  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher anti-cd44 [im7] anti-mouse, apc-efluor 780
    Anti Cd44 [Im7] Anti Mouse, Apc Efluor 780, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd44+apc+efluor+780/pmc11697717-11-3-6
    Average 90 stars, based on 1 article reviews
    anti-cd44 [im7] anti-mouse, apc-efluor 780 - by Bioz Stars, 2026-09
    90/100 stars

    Images



    Similar Products

    90
    Thermo Fisher anti-cd44 [im7] anti-mouse, apc-efluor 780
    Anti Cd44 [Im7] Anti Mouse, Apc Efluor 780, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd44+apc+efluor+780/pmc11697717-11-3-6
    Average 90 stars, based on 1 article reviews
    anti-cd44 [im7] anti-mouse, apc-efluor 780 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-mouse cd44 apc-efluor 780
    Anti Mouse Cd44 Apc Efluor 780, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd44+apc+efluor+780/pm39462230-103-99-108
    Average 90 stars, based on 1 article reviews
    anti-mouse cd44 apc-efluor 780 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher apc-efluor-780 cd44
    a Schematic diagram of allergen sensitization and challenge protocol. In the NDA mouse model, sensitization with PBS or OVA + LPS intranasally ( i.n .) was followed by challenge with PBS or OVA ( i.n .) at the indicated days. Isotype control, αIL-23p19, or dexamethasone (Dex), was treated at 1 hr before every challenge period. The inflammatory response was assessed at 48 hr after the last challenge. b Total cell, neutrophil, and eosinophil counts in BALF measured using flow ( n = 8 mice per group). c RORγt + , T-bet + , and GATA3 + Th cell counts in CD4 + T cells (Live,Dump - FOXP3 - <t>CD44</t> + CD4 + TCRb + ) measured using flow cytometry ( n = 6 mice per group). d Levels of Th17 (IL-17), Th1 (IFN-γ), and Th2 (IL-13) cell-related cytokine in BALF ( n = 8 mice per group). e Representative H&E staining of lung sections obtained from the indicated conditions. Scale bar = 100 μm. f Inflammatory scores quantified from H&E staining (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 3), OVA + LPS/OVA ( n = 3), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 5)). g Representative PAS staining of lung sections obtained from the indicated conditions. Scale bar = 200 μm. h PAS-positive area quantified from PAS staining ( n = 4 mice per group) ( i )P enh values measured using whole body plethysmography (PBS/PBS ( n = 8), OVA + LPS/PBS ( n = 9), OVA + LPS/OVA ( n = 8), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 8)). j R rs values measured using an invasive ventilated lung resistance method (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 4), OVA + LPS/OVA ( n = 5), OVA + LPS/OVA + αIL-23p19 ( n = 4), and OVA + LPS/OVA + Dex ( n = 5)). Data are shown as mean ± s.e.m. Significance was determined by one-way analysis of variance (ANOVA) with Tukey’s post hoc correction ( b – d , f , h ) and two-way ANOVA with Sidak’s post hoc correction ( i , j ).
    Apc Efluor 780 Cd44, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd44+apc+efluor+780/pmc11452667-324-71-75
    Average 90 stars, based on 1 article reviews
    apc-efluor-780 cd44 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher apc-efluor 780 conjugated anti-mouse cd44
    a Schematic diagram of allergen sensitization and challenge protocol. In the NDA mouse model, sensitization with PBS or OVA + LPS intranasally ( i.n .) was followed by challenge with PBS or OVA ( i.n .) at the indicated days. Isotype control, αIL-23p19, or dexamethasone (Dex), was treated at 1 hr before every challenge period. The inflammatory response was assessed at 48 hr after the last challenge. b Total cell, neutrophil, and eosinophil counts in BALF measured using flow ( n = 8 mice per group). c RORγt + , T-bet + , and GATA3 + Th cell counts in CD4 + T cells (Live,Dump - FOXP3 - <t>CD44</t> + CD4 + TCRb + ) measured using flow cytometry ( n = 6 mice per group). d Levels of Th17 (IL-17), Th1 (IFN-γ), and Th2 (IL-13) cell-related cytokine in BALF ( n = 8 mice per group). e Representative H&E staining of lung sections obtained from the indicated conditions. Scale bar = 100 μm. f Inflammatory scores quantified from H&E staining (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 3), OVA + LPS/OVA ( n = 3), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 5)). g Representative PAS staining of lung sections obtained from the indicated conditions. Scale bar = 200 μm. h PAS-positive area quantified from PAS staining ( n = 4 mice per group) ( i )P enh values measured using whole body plethysmography (PBS/PBS ( n = 8), OVA + LPS/PBS ( n = 9), OVA + LPS/OVA ( n = 8), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 8)). j R rs values measured using an invasive ventilated lung resistance method (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 4), OVA + LPS/OVA ( n = 5), OVA + LPS/OVA + αIL-23p19 ( n = 4), and OVA + LPS/OVA + Dex ( n = 5)). Data are shown as mean ± s.e.m. Significance was determined by one-way analysis of variance (ANOVA) with Tukey’s post hoc correction ( b – d , f , h ) and two-way ANOVA with Sidak’s post hoc correction ( i , j ).
    Apc Efluor 780 Conjugated Anti Mouse Cd44, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd44+apc+efluor+780/anti+cd44/pm37827154-286-45-55
    Average 90 stars, based on 1 article reviews
    apc-efluor 780 conjugated anti-mouse cd44 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher cd44 apc efluor 780
    a Schematic diagram of allergen sensitization and challenge protocol. In the NDA mouse model, sensitization with PBS or OVA + LPS intranasally ( i.n .) was followed by challenge with PBS or OVA ( i.n .) at the indicated days. Isotype control, αIL-23p19, or dexamethasone (Dex), was treated at 1 hr before every challenge period. The inflammatory response was assessed at 48 hr after the last challenge. b Total cell, neutrophil, and eosinophil counts in BALF measured using flow ( n = 8 mice per group). c RORγt + , T-bet + , and GATA3 + Th cell counts in CD4 + T cells (Live,Dump - FOXP3 - <t>CD44</t> + CD4 + TCRb + ) measured using flow cytometry ( n = 6 mice per group). d Levels of Th17 (IL-17), Th1 (IFN-γ), and Th2 (IL-13) cell-related cytokine in BALF ( n = 8 mice per group). e Representative H&E staining of lung sections obtained from the indicated conditions. Scale bar = 100 μm. f Inflammatory scores quantified from H&E staining (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 3), OVA + LPS/OVA ( n = 3), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 5)). g Representative PAS staining of lung sections obtained from the indicated conditions. Scale bar = 200 μm. h PAS-positive area quantified from PAS staining ( n = 4 mice per group) ( i )P enh values measured using whole body plethysmography (PBS/PBS ( n = 8), OVA + LPS/PBS ( n = 9), OVA + LPS/OVA ( n = 8), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 8)). j R rs values measured using an invasive ventilated lung resistance method (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 4), OVA + LPS/OVA ( n = 5), OVA + LPS/OVA + αIL-23p19 ( n = 4), and OVA + LPS/OVA + Dex ( n = 5)). Data are shown as mean ± s.e.m. Significance was determined by one-way analysis of variance (ANOVA) with Tukey’s post hoc correction ( b – d , f , h ) and two-way ANOVA with Sidak’s post hoc correction ( i , j ).
    Cd44 Apc Efluor 780, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd44+apc+efluor+780/pm37587343-528-44-49
    Average 86 stars, based on 1 article reviews
    cd44 apc efluor 780 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-mouse/human cd44, apc-efluor 780, rat monoclonal ab (im7)
    a Schematic diagram of allergen sensitization and challenge protocol. In the NDA mouse model, sensitization with PBS or OVA + LPS intranasally ( i.n .) was followed by challenge with PBS or OVA ( i.n .) at the indicated days. Isotype control, αIL-23p19, or dexamethasone (Dex), was treated at 1 hr before every challenge period. The inflammatory response was assessed at 48 hr after the last challenge. b Total cell, neutrophil, and eosinophil counts in BALF measured using flow ( n = 8 mice per group). c RORγt + , T-bet + , and GATA3 + Th cell counts in CD4 + T cells (Live,Dump - FOXP3 - <t>CD44</t> + CD4 + TCRb + ) measured using flow cytometry ( n = 6 mice per group). d Levels of Th17 (IL-17), Th1 (IFN-γ), and Th2 (IL-13) cell-related cytokine in BALF ( n = 8 mice per group). e Representative H&E staining of lung sections obtained from the indicated conditions. Scale bar = 100 μm. f Inflammatory scores quantified from H&E staining (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 3), OVA + LPS/OVA ( n = 3), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 5)). g Representative PAS staining of lung sections obtained from the indicated conditions. Scale bar = 200 μm. h PAS-positive area quantified from PAS staining ( n = 4 mice per group) ( i )P enh values measured using whole body plethysmography (PBS/PBS ( n = 8), OVA + LPS/PBS ( n = 9), OVA + LPS/OVA ( n = 8), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 8)). j R rs values measured using an invasive ventilated lung resistance method (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 4), OVA + LPS/OVA ( n = 5), OVA + LPS/OVA + αIL-23p19 ( n = 4), and OVA + LPS/OVA + Dex ( n = 5)). Data are shown as mean ± s.e.m. Significance was determined by one-way analysis of variance (ANOVA) with Tukey’s post hoc correction ( b – d , f , h ) and two-way ANOVA with Sidak’s post hoc correction ( i , j ).
    Anti Mouse/Human Cd44, Apc Efluor 780, Rat Monoclonal Ab (Im7), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd44+apc+efluor+780/anti+cd44/pm37172565-638-44-53
    Average 90 stars, based on 1 article reviews
    anti-mouse/human cd44, apc-efluor 780, rat monoclonal ab (im7) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-cd44 apc efluor 780 conjugate
    Antibodies used in flow cytometry experiments.
    Anti Cd44 Apc Efluor 780 Conjugate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd44+apc+efluor+780/anti+cd44/pmc09926397-6-0-6
    Average 90 stars, based on 1 article reviews
    anti-cd44 apc efluor 780 conjugate - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    a Schematic diagram of allergen sensitization and challenge protocol. In the NDA mouse model, sensitization with PBS or OVA + LPS intranasally ( i.n .) was followed by challenge with PBS or OVA ( i.n .) at the indicated days. Isotype control, αIL-23p19, or dexamethasone (Dex), was treated at 1 hr before every challenge period. The inflammatory response was assessed at 48 hr after the last challenge. b Total cell, neutrophil, and eosinophil counts in BALF measured using flow ( n = 8 mice per group). c RORγt + , T-bet + , and GATA3 + Th cell counts in CD4 + T cells (Live,Dump - FOXP3 - CD44 + CD4 + TCRb + ) measured using flow cytometry ( n = 6 mice per group). d Levels of Th17 (IL-17), Th1 (IFN-γ), and Th2 (IL-13) cell-related cytokine in BALF ( n = 8 mice per group). e Representative H&E staining of lung sections obtained from the indicated conditions. Scale bar = 100 μm. f Inflammatory scores quantified from H&E staining (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 3), OVA + LPS/OVA ( n = 3), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 5)). g Representative PAS staining of lung sections obtained from the indicated conditions. Scale bar = 200 μm. h PAS-positive area quantified from PAS staining ( n = 4 mice per group) ( i )P enh values measured using whole body plethysmography (PBS/PBS ( n = 8), OVA + LPS/PBS ( n = 9), OVA + LPS/OVA ( n = 8), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 8)). j R rs values measured using an invasive ventilated lung resistance method (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 4), OVA + LPS/OVA ( n = 5), OVA + LPS/OVA + αIL-23p19 ( n = 4), and OVA + LPS/OVA + Dex ( n = 5)). Data are shown as mean ± s.e.m. Significance was determined by one-way analysis of variance (ANOVA) with Tukey’s post hoc correction ( b – d , f , h ) and two-way ANOVA with Sidak’s post hoc correction ( i , j ).

    Journal: Nature Communications

    Article Title: Distinctive CD39 + CD9 + lung interstitial macrophages suppress IL-23/Th17-mediated neutrophilic asthma by inhibiting NETosis

    doi: 10.1038/s41467-024-53038-2

    Figure Lengend Snippet: a Schematic diagram of allergen sensitization and challenge protocol. In the NDA mouse model, sensitization with PBS or OVA + LPS intranasally ( i.n .) was followed by challenge with PBS or OVA ( i.n .) at the indicated days. Isotype control, αIL-23p19, or dexamethasone (Dex), was treated at 1 hr before every challenge period. The inflammatory response was assessed at 48 hr after the last challenge. b Total cell, neutrophil, and eosinophil counts in BALF measured using flow ( n = 8 mice per group). c RORγt + , T-bet + , and GATA3 + Th cell counts in CD4 + T cells (Live,Dump - FOXP3 - CD44 + CD4 + TCRb + ) measured using flow cytometry ( n = 6 mice per group). d Levels of Th17 (IL-17), Th1 (IFN-γ), and Th2 (IL-13) cell-related cytokine in BALF ( n = 8 mice per group). e Representative H&E staining of lung sections obtained from the indicated conditions. Scale bar = 100 μm. f Inflammatory scores quantified from H&E staining (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 3), OVA + LPS/OVA ( n = 3), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 5)). g Representative PAS staining of lung sections obtained from the indicated conditions. Scale bar = 200 μm. h PAS-positive area quantified from PAS staining ( n = 4 mice per group) ( i )P enh values measured using whole body plethysmography (PBS/PBS ( n = 8), OVA + LPS/PBS ( n = 9), OVA + LPS/OVA ( n = 8), OVA + LPS/OVA + αIL-23p19 ( n = 5), and OVA + LPS/OVA+Dex ( n = 8)). j R rs values measured using an invasive ventilated lung resistance method (PBS/PBS ( n = 3), OVA + LPS/PBS ( n = 4), OVA + LPS/OVA ( n = 5), OVA + LPS/OVA + αIL-23p19 ( n = 4), and OVA + LPS/OVA + Dex ( n = 5)). Data are shown as mean ± s.e.m. Significance was determined by one-way analysis of variance (ANOVA) with Tukey’s post hoc correction ( b – d , f , h ) and two-way ANOVA with Sidak’s post hoc correction ( i , j ).

    Article Snippet: To examine the T cell population, the lung single-cell samples were stained with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (L34957, ThermoFisher), Percp/Cyanine 5.5-anti-mouse/human CD11b (M1/70, Biolegend), Percp/Cyanine 5.5-anti-CD14 (45-0141-82, Sa2-8, eBioscience), Percp/Cyanine 5.5-anti-CD19 (115533, 6D5, Biolegend), Percp/Cyanine 5.5-anti-B220 (45-0452-82, RA3-6B2, eBioscience), Percp/Cyanine 5.5-anti-I-A/1-E (107625, M5/114.15.2, Biolegend), Brilliant Violet 605-anti-mouse TCRβ chain (109241, H57-597, Biolegend), BV421 anti-mouse RORγt (562894, Q31-378, BD), Alexa Fluor 488-anti-FOXP3 (53-5773-82, FJK-16s, eBioscience), PE-CF594-anti-T-bet (562467, O4-46, BD), APC-eFluor-780 CD44 (47-0441-82, IM7, eBioscience), Brilliant Violet-711 anti-mouse CD4 (100557, RM4-5, Biolgend), and PE-anti-GATA3 (12-9966-42, TWAJ, eBioscience).

    Techniques: Control, Flow Cytometry, Staining

    Antibodies used in flow cytometry experiments.

    Journal: Molecular Pain

    Article Title: Regulatory T-cells and IL-5 mediate pain outcomes in a preclinical model of chronic muscle pain

    doi: 10.1177/17448069221110691

    Figure Lengend Snippet: Antibodies used in flow cytometry experiments.

    Article Snippet: Anti-CD44 APC eFluor 780 conjugate , eBioscience , 47-0441-82 , 1:100 , 1 only.

    Techniques: Flow Cytometry, Purification